Malaria parasites that develop resistance to the most effective class of anti-malarial drugs may become susceptible to other treatments as a result. The discovery could reveal potential new drug options, which would be essential ...
Jun 4, 2013
0
0
(HealthDay)—For patients with advanced urothelial cancer treated with atezolizumab, proton pump inhibitor (PPI) use is a negative prognostic marker, according to a study published online Sept. 15 in Clinical Cancer Research.
Sep 16, 2020
0
5
Parents and caregivers with young babies should plan ahead when packing for their travels, whether or not children are joining the trip. Mothers who breastfeed might need to take extra precautions if they plan to pump on ...
Aug 1, 2023
0
0
Certain medications commonly used to treat heartburn, acid reflux, and ulcers are linked with higher bone fracture risks among patients on dialysis, according to a new study. Almost three-quarters of patients who had a hip ...
Sep 27, 2018
0
0
(HealthDay)—Although most gastroenterologists feel that store-brand and branded treatments are equivalent, most continue to recommend branded products for gastroesophageal reflux disease (GERD) and chronic constipation, ...
May 7, 2014
0
0
(HealthDay)—For patients with cirrhosis with previous spontaneous bacterial peritonitis (SBP), proton pump inhibitor (PPI) use is not associated with SBP recurrence, according to a study published online Nov. 7 in the Journal ...
Nov 10, 2016
0
0
Newly updated guidelines on neuroendocrine tumors developed by an expert at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine and collaborators provide clinicians with the latest recommendations ...
Apr 30, 2024
0
0
Federal regulators say nearly 29,000 controllers for implanted heart pumps are being recalled after reports of 26 deaths linked to malfunctions.
May 24, 2017
0
0
A new warning is being issued over a heart pump whose use could perforate the heart.
Apr 1, 2024
0
0
(HealthDay)—Implementation of a guideline can reduce nonindicated use of proton pump inhibitors (PPIs) and histamine-2 receptor antagonists (H2RAs) among newborns, according to a study published online Nov. 21 in Pediatrics.
Nov 22, 2017
0
0
